 Stephanie Santorico
Concepts (207)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vitiligo | 11 | 2020 | 52 | 2.190 |
Why?
| | Genome-Wide Association Study | 20 | 2021 | 1197 | 1.830 |
Why?
| | Genetic Predisposition to Disease | 11 | 2020 | 2102 | 1.190 |
Why?
| | Genetic Linkage | 3 | 2020 | 297 | 0.960 |
Why?
| | Pedigree | 4 | 2019 | 467 | 0.880 |
Why?
| | Autoimmune Diseases | 7 | 2020 | 392 | 0.850 |
Why?
| | Metabolic Syndrome | 2 | 2019 | 323 | 0.820 |
Why?
| | Meta-Analysis as Topic | 3 | 2019 | 161 | 0.760 |
Why?
| | Genetic Variation | 5 | 2018 | 876 | 0.700 |
Why?
| | DNA Fingerprinting | 1 | 2019 | 27 | 0.680 |
Why?
| | Polymorphism, Single Nucleotide | 13 | 2020 | 1893 | 0.660 |
Why?
| | Siblings | 1 | 2019 | 223 | 0.630 |
Why?
| | Genetic Association Studies | 3 | 2016 | 345 | 0.600 |
Why?
| | Models, Statistical | 1 | 2019 | 604 | 0.520 |
Why?
| | Face | 4 | 2017 | 168 | 0.490 |
Why?
| | Tongue | 1 | 2015 | 67 | 0.490 |
Why?
| | Sequence Analysis, DNA | 3 | 2016 | 729 | 0.440 |
Why?
| | Taste Buds | 1 | 2015 | 209 | 0.410 |
Why?
| | Genotype | 10 | 2020 | 1775 | 0.410 |
Why?
| | Parents | 1 | 2019 | 1191 | 0.390 |
Why?
| | Haplotypes | 5 | 2020 | 453 | 0.380 |
Why?
| | Multifactorial Inheritance | 3 | 2020 | 125 | 0.350 |
Why?
| | Quantitative Trait Loci | 2 | 2016 | 308 | 0.350 |
Why?
| | Biostatistics | 1 | 2010 | 16 | 0.340 |
Why?
| | Phenotype | 9 | 2019 | 2817 | 0.310 |
Why?
| | Maxillofacial Development | 3 | 2016 | 18 | 0.310 |
Why?
| | Models, Genetic | 3 | 2019 | 565 | 0.280 |
Why?
| | Smoking | 3 | 2019 | 1391 | 0.240 |
Why?
| | Age of Onset | 3 | 2020 | 448 | 0.230 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 3 | 2018 | 928 | 0.230 |
Why?
| | Gene Frequency | 3 | 2020 | 481 | 0.230 |
Why?
| | Humans | 35 | 2021 | 114937 | 0.230 |
Why?
| | High-Throughput Nucleotide Sequencing | 2 | 2018 | 441 | 0.220 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2019 | 2096 | 0.210 |
Why?
| | Image Processing, Computer-Assisted | 2 | 2017 | 686 | 0.200 |
Why?
| | DNA Copy Number Variations | 1 | 2021 | 159 | 0.180 |
Why?
| | Forensic Genetics | 1 | 2019 | 4 | 0.170 |
Why?
| | Male | 20 | 2021 | 55663 | 0.170 |
Why?
| | Immune System Diseases | 1 | 2019 | 34 | 0.170 |
Why?
| | Genes | 1 | 2019 | 224 | 0.160 |
Why?
| | HLA-DQ Antigens | 2 | 2019 | 176 | 0.160 |
Why?
| | Genes, MHC Class II | 1 | 2019 | 70 | 0.160 |
Why?
| | Mexican Americans | 1 | 2019 | 102 | 0.160 |
Why?
| | Deafness | 1 | 2019 | 79 | 0.150 |
Why?
| | Genome, Human | 2 | 2021 | 352 | 0.150 |
Why?
| | Gene-Environment Interaction | 1 | 2019 | 184 | 0.150 |
Why?
| | Hearing | 1 | 2019 | 136 | 0.150 |
Why?
| | Facial Bones | 1 | 2017 | 32 | 0.150 |
Why?
| | Linoleic Acid | 1 | 2017 | 38 | 0.150 |
Why?
| | Feces | 2 | 2016 | 374 | 0.140 |
Why?
| | Biometric Identification | 1 | 2017 | 1 | 0.140 |
Why?
| | Risk Assessment | 4 | 2019 | 2975 | 0.140 |
Why?
| | Malnutrition | 1 | 2017 | 61 | 0.140 |
Why?
| | Respiratory Function Tests | 1 | 2018 | 524 | 0.140 |
Why?
| | 3',5'-Cyclic-AMP Phosphodiesterases | 1 | 2016 | 12 | 0.140 |
Why?
| | Linear Models | 2 | 2016 | 770 | 0.140 |
Why?
| | Interferon-Induced Helicase, IFIH1 | 1 | 2016 | 14 | 0.140 |
Why?
| | Imaging, Three-Dimensional | 2 | 2017 | 517 | 0.140 |
Why?
| | Pharynx | 1 | 2016 | 50 | 0.130 |
Why?
| | Air Pollutants | 1 | 2019 | 244 | 0.130 |
Why?
| | Lipoproteins | 1 | 2017 | 160 | 0.130 |
Why?
| | HLA-A Antigens | 1 | 2016 | 50 | 0.130 |
Why?
| | Quantitative Trait, Heritable | 1 | 2016 | 117 | 0.130 |
Why?
| | RNA, Long Noncoding | 1 | 2018 | 154 | 0.130 |
Why?
| | Delivery, Obstetric | 1 | 2016 | 119 | 0.130 |
Why?
| | Taste | 1 | 2017 | 209 | 0.130 |
Why?
| | Schizophrenia | 1 | 2019 | 415 | 0.130 |
Why?
| | Vaccines, Conjugate | 1 | 2015 | 60 | 0.120 |
Why?
| | Nasopharynx | 1 | 2015 | 63 | 0.120 |
Why?
| | Milk, Human | 1 | 2016 | 128 | 0.120 |
Why?
| | Staining and Labeling | 1 | 2015 | 134 | 0.120 |
Why?
| | HLA-DR Antigens | 1 | 2016 | 220 | 0.120 |
Why?
| | Photography | 1 | 2015 | 89 | 0.120 |
Why?
| | Leptin | 1 | 2016 | 211 | 0.120 |
Why?
| | Tanzania | 3 | 2021 | 44 | 0.120 |
Why?
| | Genetic Heterogeneity | 1 | 2014 | 49 | 0.120 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2016 | 353 | 0.120 |
Why?
| | Female | 18 | 2021 | 59581 | 0.120 |
Why?
| | Pneumococcal Vaccines | 1 | 2015 | 132 | 0.110 |
Why?
| | Child Development | 1 | 2017 | 387 | 0.110 |
Why?
| | Atherosclerosis | 1 | 2017 | 342 | 0.110 |
Why?
| | Risk Factors | 7 | 2020 | 8637 | 0.110 |
Why?
| | Intestines | 1 | 2016 | 326 | 0.110 |
Why?
| | Respiratory Tract Diseases | 1 | 2014 | 140 | 0.110 |
Why?
| | Lipase | 1 | 2013 | 57 | 0.110 |
Why?
| | Carrier Proteins | 1 | 2016 | 696 | 0.100 |
Why?
| | Microbiota | 2 | 2016 | 649 | 0.100 |
Why?
| | Tomography, X-Ray Computed | 2 | 2018 | 2326 | 0.100 |
Why?
| | Mutation, Missense | 1 | 2013 | 295 | 0.090 |
Why?
| | Immunity, Innate | 1 | 2016 | 725 | 0.090 |
Why?
| | Pulmonary Emphysema | 1 | 2014 | 280 | 0.090 |
Why?
| | Genetic Pleiotropy | 1 | 2010 | 29 | 0.090 |
Why?
| | Lipoproteins, HDL | 1 | 2010 | 76 | 0.090 |
Why?
| | Gene Expression Regulation | 2 | 2019 | 2324 | 0.090 |
Why?
| | Chromosomes, Human, Pair 1 | 1 | 2010 | 67 | 0.090 |
Why?
| | Middle Aged | 8 | 2019 | 26806 | 0.090 |
Why?
| | Transcription, Genetic | 1 | 2016 | 1317 | 0.090 |
Why?
| | Gastrointestinal Microbiome | 1 | 2016 | 502 | 0.080 |
Why?
| | Statistics as Topic | 1 | 2010 | 294 | 0.080 |
Why?
| | Genetic Markers | 1 | 2010 | 322 | 0.080 |
Why?
| | Family Health | 1 | 2010 | 194 | 0.080 |
Why?
| | Chromosome Mapping | 1 | 2010 | 490 | 0.080 |
Why?
| | Adult | 8 | 2019 | 30608 | 0.080 |
Why?
| | Aged | 6 | 2019 | 19122 | 0.080 |
Why?
| | Triglycerides | 1 | 2010 | 470 | 0.080 |
Why?
| | Cytokines | 1 | 2016 | 1843 | 0.080 |
Why?
| | Blood Pressure | 1 | 2014 | 1537 | 0.080 |
Why?
| | Bayes Theorem | 1 | 2010 | 331 | 0.080 |
Why?
| | Child, Preschool | 5 | 2021 | 9086 | 0.070 |
Why?
| | Software | 1 | 2010 | 537 | 0.070 |
Why?
| | Incidence | 3 | 2019 | 2316 | 0.070 |
Why?
| | Insulin | 1 | 2016 | 2079 | 0.070 |
Why?
| | Hypertension | 1 | 2014 | 1059 | 0.070 |
Why?
| | United States | 4 | 2019 | 12211 | 0.070 |
Why?
| | Family | 2 | 2020 | 590 | 0.060 |
Why?
| | Hospitalization | 1 | 2014 | 1754 | 0.060 |
Why?
| | Adolescent | 6 | 2019 | 17829 | 0.060 |
Why?
| | Child | 6 | 2021 | 18366 | 0.060 |
Why?
| | Cohort Studies | 3 | 2021 | 4903 | 0.060 |
Why?
| | Alleles | 2 | 2019 | 791 | 0.060 |
Why?
| | Infant | 4 | 2019 | 7937 | 0.060 |
Why?
| | Proportional Hazards Models | 2 | 2018 | 1080 | 0.060 |
Why?
| | Prevalence | 2 | 2019 | 2252 | 0.050 |
Why?
| | Aged, 80 and over | 3 | 2019 | 6364 | 0.050 |
Why?
| | Young Adult | 4 | 2019 | 10478 | 0.050 |
Why?
| | Case-Control Studies | 2 | 2019 | 3008 | 0.050 |
Why?
| | Cyclic Nucleotide Phosphodiesterases, Type 7 | 1 | 2019 | 1 | 0.040 |
Why?
| | Japan | 1 | 2019 | 87 | 0.040 |
Why?
| | HLA-DQ beta-Chains | 1 | 2019 | 58 | 0.040 |
Why?
| | Poisson Distribution | 1 | 2018 | 72 | 0.040 |
Why?
| | Factor Analysis, Statistical | 1 | 2018 | 257 | 0.040 |
Why?
| | Growth | 1 | 2017 | 56 | 0.040 |
Why?
| | Taste Perception | 1 | 2017 | 22 | 0.040 |
Why?
| | Genetic Loci | 1 | 2019 | 263 | 0.040 |
Why?
| | Infant, Newborn | 2 | 2019 | 5035 | 0.040 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2019 | 369 | 0.040 |
Why?
| | Repressor Proteins | 1 | 2019 | 368 | 0.030 |
Why?
| | Cross-Sectional Studies | 2 | 2017 | 4407 | 0.030 |
Why?
| | Cause of Death | 1 | 2018 | 363 | 0.030 |
Why?
| | Lactobacillales | 1 | 2016 | 6 | 0.030 |
Why?
| | Gammaproteobacteria | 1 | 2016 | 14 | 0.030 |
Why?
| | Pyruvate Kinase | 1 | 2016 | 20 | 0.030 |
Why?
| | Anthropometry | 1 | 2016 | 180 | 0.030 |
Why?
| | Fatty Acids, Volatile | 1 | 2016 | 47 | 0.030 |
Why?
| | Monocytes | 1 | 2019 | 504 | 0.030 |
Why?
| | Plethysmography | 1 | 2016 | 104 | 0.030 |
Why?
| | Up-Regulation | 1 | 2019 | 812 | 0.030 |
Why?
| | Dendritic Cells | 1 | 2019 | 436 | 0.030 |
Why?
| | Morphogenesis | 1 | 2016 | 161 | 0.030 |
Why?
| | Follow-Up Studies | 2 | 2014 | 4427 | 0.030 |
Why?
| | Rectum | 1 | 2016 | 153 | 0.030 |
Why?
| | Kenya | 1 | 2015 | 97 | 0.030 |
Why?
| | Corynebacterium | 1 | 2015 | 36 | 0.030 |
Why?
| | Vagina | 1 | 2016 | 146 | 0.030 |
Why?
| | Enhancer Elements, Genetic | 1 | 2016 | 152 | 0.030 |
Why?
| | Computer Simulation | 1 | 2018 | 880 | 0.030 |
Why?
| | Streptococcus pneumoniae | 1 | 2015 | 134 | 0.030 |
Why?
| | Membrane Proteins | 1 | 2019 | 1022 | 0.030 |
Why?
| | Polymerase Chain Reaction | 1 | 2016 | 995 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2018 | 1801 | 0.030 |
Why?
| | Spirometry | 1 | 2014 | 225 | 0.030 |
Why?
| | Phospholipases | 1 | 2013 | 13 | 0.030 |
Why?
| | Heparan Sulfate Proteoglycans | 1 | 2013 | 22 | 0.030 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2015 | 486 | 0.030 |
Why?
| | Hydrolysis | 1 | 2013 | 175 | 0.030 |
Why?
| | Breast Feeding | 1 | 2016 | 370 | 0.030 |
Why?
| | Cluster Analysis | 1 | 2014 | 460 | 0.030 |
Why?
| | Body Composition | 1 | 2016 | 585 | 0.030 |
Why?
| | Sequence Alignment | 1 | 2013 | 325 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2016 | 1440 | 0.030 |
Why?
| | Sex Factors | 1 | 2017 | 1721 | 0.030 |
Why?
| | Cholesterol, HDL | 1 | 2013 | 184 | 0.030 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2013 | 132 | 0.030 |
Why?
| | Skin | 1 | 2016 | 659 | 0.020 |
Why?
| | Protein Multimerization | 1 | 2013 | 159 | 0.020 |
Why?
| | Structure-Activity Relationship | 1 | 2013 | 503 | 0.020 |
Why?
| | Acute Disease | 1 | 2014 | 915 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2019 | 2559 | 0.020 |
Why?
| | Algorithms | 1 | 2018 | 1474 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 2016 | 1133 | 0.020 |
Why?
| | Cholesterol | 1 | 2013 | 368 | 0.020 |
Why?
| | Enzyme Activation | 1 | 2013 | 790 | 0.020 |
Why?
| | Melanoma | 1 | 2016 | 631 | 0.020 |
Why?
| | Protein Conformation | 1 | 2013 | 811 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2013 | 1988 | 0.020 |
Why?
| | Prognosis | 1 | 2016 | 3344 | 0.020 |
Why?
| | Body Mass Index | 1 | 2016 | 1961 | 0.020 |
Why?
| | Transcription Factors | 1 | 2016 | 1530 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2013 | 2791 | 0.020 |
Why?
| | Models, Molecular | 1 | 2013 | 1379 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2014 | 2382 | 0.020 |
Why?
| | Protein Binding | 1 | 2013 | 1897 | 0.020 |
Why?
| | Vaccination | 1 | 2015 | 1205 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2014 | 2542 | 0.020 |
Why?
| | Lung | 1 | 2018 | 3593 | 0.020 |
Why?
| | Biomarkers | 1 | 2016 | 3418 | 0.020 |
Why?
| | Models, Biological | 1 | 2013 | 1630 | 0.020 |
Why?
| | Prospective Studies | 1 | 2016 | 6218 | 0.020 |
Why?
| | Pregnancy | 1 | 2016 | 5527 | 0.020 |
Why?
| | Obesity | 1 | 2016 | 2514 | 0.010 |
Why?
| | Quality of Life | 1 | 2014 | 2359 | 0.010 |
Why?
| | Colorado | 1 | 2013 | 4091 | 0.010 |
Why?
| | Inflammation | 1 | 2013 | 2485 | 0.010 |
Why?
| | Mice | 1 | 2016 | 14936 | 0.010 |
Why?
| | Signal Transduction | 1 | 2013 | 4525 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2014 | 12544 | 0.010 |
Why?
| | Animals | 1 | 2016 | 31839 | 0.010 |
Why?
|
|
Santorico's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|